Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Catania
Clinical trial register · Italy

Clinical Trials in Catania, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 137 Naples 79 Roma 71 Florence 57 Padova 56
Narrow the registerReset
Recruitment status
Phase
Site location
Milan137 Naples79 Roma71 Florence57 Padova56
All 111 locations
Target enrolment
to

Trials with a site in Catania

22 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Recruiting
AstraZeneca
Phase 3
4,500
Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna
2026-06-29
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
AstraZeneca
Phase 2
278
Aviano, Catania, Meldola, Milan, Orbassano, Roma, Rozzano
2025-08-07
Recruiting
AstraZeneca
Phase 3
800
Alessandria, Aviano, Bari, Bologna, Catania, Florence, Haifa, Milan
2025-08-01
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Recruiting
AstraZeneca
Phase 3
3,850
Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona
2024-04-12
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Active, closed
AstraZeneca
Observational
151
Alessandria, Ancona, Bari, Barletta, Brindisi, Campobasso, Catania, Catanzaro
2023-08-08
Recruiting
AstraZeneca
Phase 3
4,300
Bari, Catania, Catanzaro, Florence, Genova, Grosseto, Milan, Modena
2023-03-31
Active, closed
AstraZeneca
Phase 3
341
Avellino, Aviano, Catania, Meldola, Milan, Modena, Monserrato, Naples
2022-08-03
By invitation
AstraZeneca
Phase 3
214
Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa
2022-04-19
Active, closed
AstraZeneca
Phase 3
390
Bari, Catania, Florence, Genova, Milan, Naples, Padova, Parma
2022-02-21
Active, closed
AstraZeneca
Phase 3
506
Ancona, Bergamo, Catania, Milan, Naples, Padova, Prato
2021-06-22
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
AstraZeneca
Phase 2
247
Catania, Naples, Orbassano, Padova, Varese
2019-06-25
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/catania

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Catania that also match the filters currently applied.

How many clinical trials are recruiting in Catania?

13 of the 22 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Catania), 22 studies
PhaseStudiesRecruitingShare
Phase 3181181.8%
Phase 23213.6%
Observational104.5%

Most active sponsors

Lead sponsors with the most studies (Catania)
Lead sponsorStudiesRecruiting
AstraZeneca2213
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.